Herein, we describe the first live organism transgenic model of TMEM106B C-terminal proteinopathy generated by expressing the TMEM106B C-terminal aggregation prone fragment constituting the fibrillar core in FTLD cases. Here, TMEM106B is linked to proteostasis deficiencies.